Affimed NV Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Affimed NV Stock Summary

Affimed NV competes with Pieris Pharmaceuticals, ADC Therapeutics, Agenus, X4 Pharmaceuticals, and Terns Pharmaceuticals. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 197 people.

Affimed NV Key Financial Ratios

Affimed NV Key Balance Sheet Accounts

Affimed NV Key Income Statement Accounts

Affimed NV Key Cash Accounts

Affimed Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Affimed NV's current stock value. Our valuation model uses many indicators to compare Affimed NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Affimed NV competition to find correlations between indicators driving Affimed NV's intrinsic value. More Info.Affimed NV is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Affimed NV's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Affimed NV by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Affimed NV Systematic Risk

Today, most investors in Affimed NV Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Affimed NV's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Affimed NV growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Affimed NV help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Affimed NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Affimed NV based on widely used predictive technical indicators. In general, we focus on analyzing Affimed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Affimed NV's daily price indicators and compare them against related drivers.

When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.